Department for Hearing, Speech and Voice Disorders, Medical University of Innsbruck, Innsbruck, Austria.
Department for Hearing, Speech and Voice Disorders, Tirol Kliniken GmbH, Innsbruck, Austria.
Otol Neurotol. 2023 Mar 1;44(3):e155-e159. doi: 10.1097/MAO.0000000000003809. Epub 2023 Jan 18.
Only few studies assessed health-related quality of life (HRQoL) in cochlear implant (CI) patients for a period of more than 2 years. Some of these studies indicated that HRQoL might decrease after that period. The goal of our study was to see whether HRQoL indeed decreases or remains stable beyond 2 years after implant activation.
Twenty-five adults (11 women, 14 men; mean age at implantation: 60 ± 19 yr) with a unilateral CI for profound hearing loss were administered two questionnaires: the Nimjegen Cochlear Implant Questionnaire and the Health Utility Index 3 (HUI 3). The Nimjegen Cochlear Implant Questionnaire total score and the HUI single-attribute utility score of Hearing are measures of hearing-specific HRQoL, whereas the HUI multiattribute utility score is a measure of generic HRQoL. The questionnaires were administered before cochlear implantation and 1, 2, and 5 years after implant activation.
Hearing-specific HRQoL was significantly improved at 1 year after implant activation and did not significantly change thereafter. Generic HRQoL also showed significant improvement at 1 year after implant activation, but deteriorated to a clinically relevant degree thereafter.
The significant improvement of hearing-specific HRQoL obtained from cochlear implantation was fully maintained for up to 5 years after implantation. Generic HRQoL of our CI patients, however, fluctuated over time. The decrease of generic HRQoL is supposed to reflect general age-associated health declines.
仅有少数研究评估了植入人工耳蜗(CI)后超过 2 年的患者的健康相关生活质量(HRQoL)。其中一些研究表明,在此期间后,HRQoL 可能会下降。我们的研究目的是观察 HRQoL 是否确实在植入激活后超过 2 年下降或保持稳定。
25 名成年人(11 名女性,14 名男性;植入时的平均年龄:60 ± 19 岁)单侧植入人工耳蜗用于深度听力损失,他们接受了两份问卷:尼梅根人工耳蜗问卷和健康效用指数 3(HUI 3)。尼梅根人工耳蜗问卷总分和 HUI 听力单一属性效用评分是衡量听力特异性 HRQoL 的指标,而 HUI 多属性效用评分是衡量通用 HRQoL 的指标。问卷在植入前和植入激活后 1、2 和 5 年进行。
植入后 1 年,听力特异性 HRQoL 显著改善,此后无显著变化。通用 HRQoL 也在植入后 1 年显著改善,但此后恶化到具有临床意义的程度。
人工耳蜗植入后获得的听力特异性 HRQoL 的显著改善在植入后长达 5 年内得到维持。然而,我们的 CI 患者的通用 HRQoL 随时间波动。通用 HRQoL 的下降被认为反映了与年龄相关的一般健康下降。